1889 Stock Overview
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Sanai Health Industry Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.34 |
| 52 Week High | HK$1.85 |
| 52 Week Low | HK$0.19 |
| Beta | -1.19 |
| 1 Month Change | -13.75% |
| 3 Month Change | -46.09% |
| 1 Year Change | -71.25% |
| 3 Year Change | -86.47% |
| 5 Year Change | -84.67% |
| Change since IPO | -99.30% |
Recent News & Updates
Little Excitement Around Sanai Health Industry Group Company Limited's (HKG:1889) Earnings As Shares Take 29% Pounding
Nov 28
Is Sanai Health Industry Group (HKG:1889) A Risky Investment?
Nov 27Sanai Health Industry Group's (HKG:1889) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Oct 03Sanai Health Industry Group Company Limited (HKG:1889) Looks Inexpensive After Falling 45% But Perhaps Not Attractive Enough
Sep 03Recent updates
Little Excitement Around Sanai Health Industry Group Company Limited's (HKG:1889) Earnings As Shares Take 29% Pounding
Nov 28Is Sanai Health Industry Group (HKG:1889) A Risky Investment?
Nov 27Sanai Health Industry Group's (HKG:1889) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Oct 03Sanai Health Industry Group Company Limited (HKG:1889) Looks Inexpensive After Falling 45% But Perhaps Not Attractive Enough
Sep 03Sanai Health Industry Group Company Limited (HKG:1889) Might Not Be As Mispriced As It Looks After Plunging 29%
Jun 28Is Sanai Health Industry Group (HKG:1889) Using Too Much Debt?
Jun 07Positive Sentiment Still Eludes Sanai Health Industry Group Company Limited (HKG:1889) Following 26% Share Price Slump
Apr 03Improved Earnings Required Before Sanai Health Industry Group Company Limited (HKG:1889) Shares Find Their Feet
Jan 23What Sanai Health Industry Group Company Limited's (HKG:1889) 35% Share Price Gain Is Not Telling You
May 15We Like The Quality Of Sanai Health Industry Group's (HKG:1889) Earnings
Sep 23Shareholder Returns
| 1889 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 3.0% | 0.8% | 0.4% |
| 1Y | -71.3% | 6.7% | 24.4% |
Return vs Industry: 1889 underperformed the Hong Kong Pharmaceuticals industry which returned 6.7% over the past year.
Return vs Market: 1889 underperformed the Hong Kong Market which returned 24.4% over the past year.
Price Volatility
| 1889 volatility | |
|---|---|
| 1889 Average Weekly Movement | 16.0% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in HK Market | 13.9% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 1889's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1889's weekly volatility has decreased from 39% to 16% over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 156 | n/a | www.1889hk.com |
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services.
Sanai Health Industry Group Company Limited Fundamentals Summary
| 1889 fundamental statistics | |
|---|---|
| Market cap | HK$52.75m |
| Earnings (TTM) | HK$14.04m |
| Revenue (TTM) | HK$104.82m |
3.8x
P/E Ratio0.5x
P/S RatioIs 1889 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1889 income statement (TTM) | |
|---|---|
| Revenue | CN¥97.54m |
| Cost of Revenue | CN¥79.99m |
| Gross Profit | CN¥17.55m |
| Other Expenses | CN¥4.49m |
| Earnings | CN¥13.06m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.085 |
| Gross Margin | 17.99% |
| Net Profit Margin | 13.39% |
| Debt/Equity Ratio | 11.8% |
How did 1889 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 07:58 |
| End of Day Share Price | 2025/01/28 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sanai Health Industry Group Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Soo Ang | Daiwa Securities Co. Ltd. |